Your session is about to expire
Combipatch vs Climara Pro
Introduction
For women experiencing menopausal symptoms, certain hormone replacement therapies (HRT) can help manage uncomfortable symptoms like hot flashes and night sweats. Combipatch and Climara Pro are two such HRTs that doctors prescribe for this purpose. Both medications work by releasing hormones into the body to replace those that decrease during menopause, but they do so in different ways. The Combipatch is a combination of estradiol (a form of estrogen) and norethindrone acetate (a type of progestin) which helps balance hormone levels, while also protecting the uterus against hyperplasia caused by estrogen alone. On the other hand, Climara Pro provides both estradiol and levonorgestrel (another form of progestin), primarily managing menopausal symptoms while offering protection from endometrial hyperplasia.
Combipatch vs Climara Pro Side By Side
| Attribute | Combipatch | Climara pro |
|---|---|---|
| Brand Name | Combipatch | Climara Pro |
| Contraindications | History of strokes or heart attacks, liver disease, hormone-sensitive cancers like breast or uterine cancer, blood clotting disorders | History of strokes or heart attacks, liver disease, hormone-sensitive cancers like breast or uterine cancer, blood clotting disorders |
| Cost | About $140 for 8 patches (0.05 mg/14 mcg) | About $130 for 4 patches (0.045 mg/15 mcg) |
| Generic Name | No direct generic equivalent available | No direct generic equivalent available |
| Most Serious Side Effect | Unexpected vaginal bleeding, chest pain, sudden vision loss, swelling in hands/ankles/feet, liver problems, high blood pressure | Signs of an allergic reaction, unusual vaginal bleeding, lump in breast, confusion, heart attack symptoms, liver problems, high calcium levels in blood |
| Severe Drug Interactions | Not explicitly mentioned, but interactions may exacerbate contraindications | Not explicitly mentioned, but interactions may exacerbate contraindications |
| Typical Dose | One patch (0.05 mg/day norethindrone acetate and 0.14 mg/day estradiol) applied twice weekly | One patch (0.045 mg/day estradiol and 0.015 mg/day levonorgestrel) applied once weekly |
What is Combipatch?
Combipatch and Climara Pro are both hormone replacement therapies used during menopause to help balance estrogen and progesterone levels. However, their compositions and usage differ significantly. Combipatch combines estradiol (a form of estrogen) with norethindrone acetate (a type of progestin), which is typically applied twice weekly for the treatment of moderate to severe vasomotor symptoms associated with menopause or postmenopausal osteoporosis in women who have a uterus. This hormonal combination aims at minimizing endometrial hyperplasia risk due to the introduction of estrogens.
On the other hand, Climara Pro contains both estradiol and levonorgestrel (another kind of progestin). It's designed as a once-a-week patch that gradually releases hormones through your skin into your bloodstream. Like Combipatch, it aids in managing hot flashes linked with menopause and prevents osteoporosis after menopause.
Both drugs aim to restore hormonal balance but differ slightly concerning their formulation, frequency of use, side effects profiled, but choosing between them largely depends on individual tolerability or specific needs under physician direction.
What conditions is Combipatch approved to treat?
Combipatch is approved for the treatment of various symptoms in postmenopausal women:
- Prevention of postmenopausal osteoporosis
- Treatment of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats
- Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause. However, topical vaginal products are preferred for this use due to their lower risks compared to systemic estrogen therapy.
How does Combipatch help with these illnesses?
Combipatch helps to manage menopausal symptoms by supplying a combination of estrogen and progesterone hormones. It does this by delivering these hormones directly through the skin, where they can be absorbed into the bloodstream and used throughout the body. Estrogen is a hormone that plays an important role in regulating menstrual cycles, maintaining bone density, distributing fat in the body, amongst other things. During menopause, women's bodies naturally produce less estrogen which often results in uncomfortable symptoms such as hot flashes or vaginal dryness. Progesterone is another hormone that prepares the uterus for implantation of a fertilized egg and maintains pregnancy; when used along with estrogen it prevents overgrowth of uterine lining thus reducing risk of uterine cancer. Therefore, by supplying both hormones externally through Combipatch patches, women can reduce many negative effects associated with menopause and maintain their comfort level.
What is Climara Pro?
Climara Pro is a brand name for the combination of estradiol and levonorgestrel, two hormones that are used to treat symptoms of menopause such as hot flashes and vaginal changes (dryness and atrophy). Additionally, this medication helps prevent osteoporosis after menopause. Climara Pro comes in the form of a transdermal patch which slowly releases small amounts of these hormones directly into your bloodstream through the skin. This method allows it to bypass first-pass metabolism by the liver. It was approved by the FDA in 2003.
Unlike Combipatch, which contains both an estrogen (estradiol) and progesterone hormone (norethindrone), Climara Pro does not contain any progesterone component. The absence of progesterone can be beneficial because it reduces some side effects associated with progestin use like bloating or mood swings. However, women who still have their uterus need to take a progestin along with estradiol products like Climara Pro to protect against endometrial cancer.
The primary benefit observed from using Climara Pro over typical systemic oral therapies may include fewer gastrointestinal side effects since it bypasses digestion entirely.
What conditions is Climara Pro approved to treat?
The FDA has approved Climara Pro for the management of:
- Vasomotor symptoms associated with menopause, such as hot flashes and night sweats
- The prevention of postmenopausal osteoporosis
How does Climara Pro help with these illnesses?
Estradiol and levonorgestrel are hormones that play crucial roles in the female reproductive system, affecting menstrual cycles, pregnancy, menopause symptoms, and more. Climara Pro works by supplying a steady dose of these two hormones to aid women who have lower levels due to menopause or other conditions. Its action on estradiol helps alleviate some of the symptoms of menopause like hot flashes or vaginal dryness. The inclusion of levonorgestrel serves as an added progestin component for those with an intact uterus to reduce the risk of endometrial hyperplasia which could lead to uterine cancer if left unchecked. Since it delivers a consistent quantity over time through its transdermal patch application method, it is sometimes prescribed when a patient does not respond well or experiences side effects from fluctuating hormone levels present with oral medications or other hormone replacement therapies such as Combipatch.
How effective are both Combipatch and Climara Pro?
Combipatch and Climara Pro are both transdermal patches designed to deliver hormone replacement therapy for postmenopausal women. They were approved by the FDA only a few years apart, with Combipatch receiving approval in 1998 and Climara Pro in 2003. Each patch contains an estrogen (estradiol) plus a progestogen to protect the uterus from endometrial hyperplasia.
In terms of efficacy, both Combipatch and Climara Pro have been shown to improve vasomotor symptoms associated with menopause such as hot flashes and night sweats. A direct comparison between these two products has not yet been conducted, but individual studies indicate that they may offer comparable relief.
A long-term study published in 2001 found that Combipatch effectively reduced frequency of hot flashes over six cycles of treatment while maintaining endometrial safety and overall tolerability among users. The optimal dose is thought to be dependent on individual patient characteristics, given the variable nature of menopausal symptoms.
Meanwhile, a 2003 clinical trial demonstrated similar findings for Climara Pro; it significantly reduced the number, duration, and severity of hot flashes after just one week of use compared to placebo. Its side effect profile was also favorable when used at recommended doses.
It's important however for patients considering either option to understand that while beneficial at reducing menopausal symptoms, hormone replacement therapies do carry some risks including potential cardiovascular complications or increased risk of certain cancers which should be discussed thoroughly with their healthcare provider. As always personal medical history will greatly influence suitability for either medication.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Combipatch typically prescribed?
Dosage of Combipatch for postmenopausal hormone replacement therapy typically begins with one patch (0.05 mg/day norethindrone acetate and 0.14 mg/day estradiol) applied twice weekly on a continuous sequential basis. If necessary, dosage can be adjusted after a few weeks based on the response. The maximum dosage that should not be exceeded is two patches per week. On the other hand, Climara Pro is usually prescribed as one patch (containing 0.045 mg/day estradiol and 0.015 mg/day levonorgestrel) applied once weekly on a continuous basis without any breaks between patches.
At what dose is Climara Pro typically prescribed?
Climara Pro therapy typically begins with a single patch applied to the skin once weekly. Each patch delivers a daily dose of 0.045 mg/day estradiol and 0.015 mg/day levonorgestrel, which is released continuously over the course of one week. The Climara Pro patch should be replaced every seven days, preferably on the same day each week for consistency and best results. If after several weeks there appears to be no significant response or improvement in menopausal symptoms, your healthcare provider may consider adjusting the dosage or frequency.
What are the most common side effects for Combipatch?
Common side effects of Combipatch may include:
- Headache
- Breast pain or tenderness
- Nausea, vomiting, bloating
- Stomach cramps
- Hair loss
- Vaginal itching or discharge, discomfort during sexual intercourse
- Changes in menstrual periods, breakthrough bleeding
- Weight gain
On the other hand, some common side effects of Climara Pro are:
- Skin redness/irritation at the application site,
- Itching, rash,
- Abdominal pain,
- Nausea/vomiting, and - Swelling hands/ankles/feet.
These lists do not include all possible side effects. Depending on your condition and medical history, these medications can have different impacts. Always consult with a health professional before starting new medication.
Are there any potential serious side effects for Combipatch?
While Combipatch and Climara Pro are both effective treatments for menopause symptoms, they can have different side effects. Here are some potential serious adverse reactions that may occur from using Combipatch:
- Signs of an allergic reaction including hives; difficult breathing; swelling of your face, lips, tongue or throat
- Unexpected vaginal bleeding
- Chest pain or heavy feeling, pain spreading to the jaw or shoulder, nausea, sweating
- Sudden vision loss or blurred vision;
- Swelling in your hands, ankles or feet; low calcium levels - muscle spasms or contractions (tetany), numbness or tingly feeling around the mouth
- Liver problems - nausea and vomiting leading to loss of appetite which might lead to upper stomach pain and tiredness with jaundice (yellowing of skin/eyes)
- High blood pressure - severe headache blurred vision pounding in neck/ears anxiety shortness of breath
If you experience any such symptoms while on Combipatch therapy stop medication immediately and seek medical attention.
What are the most common side effects for Climara Pro?
Climara Pro, like many medications, has a range of potential side effects that should be monitored:
- Irritation or redness at the application site
- Headache or migraine
- Nausea, vomiting and abdominal discomfort
- Breast tenderness or pain
- Swelling in hands, ankles or feet (edema)
- Changes in menstrual periods
- Mood changes such as depression or anxiety
- Unusual vaginal bleeding Moreover, it's important to remember that serious but less common side effects can occur with Climara Pro including blood clots and stroke. Therefore, any sudden dizziness, confusion or severe headaches require immediate medical attention.
Are there any potential serious side effects for Climara Pro?
While Climara Pro is typically well-tolerated, it can cause serious side effects in rare cases. Some symptoms to watch out for include:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat
- Unusual vaginal bleeding that has not been checked by a doctor
- A lump in your breast
- Confusion, unusual behavior or thoughts (especially in older adults)
- Heart attack symptoms: chest pain or pressure, pain spreading to your jaw or shoulder; nausea and sweating
- Liver problems: nausea, upper stomach pain, itching, tiredness; loss of appetite; dark urine and clay-colored stools; jaundice (yellowing of the skin or eyes)
- High levels of calcium in your blood: nausea, constipation increased thirst/urination.
If any these signs are noticed after starting treatment with Climara Pro patch immediately consult with a healthcare professional.
Contraindications for Combipatch and Climara Pro?
Both Combipatch and Climara Pro, like many other hormone replacement therapies, may exacerbate certain symptoms in some individuals. If you notice an increase in high blood pressure, migraines, or unusual vaginal bleeding, please seek immediate medical attention.
Neither Combipatch nor Climara Pro should be used if you have a history of strokes or heart attacks. You should also avoid these medications if you have liver disease or any type of cancer that is sensitive to hormones such as breast cancer or uterine cancer.
Always inform your healthcare provider about all the medications you are taking; some drugs can interfere with the efficacy of hormone replacement therapy and vice versa. It's also important to mention other health issues—like blood clotting disorders—as using either Combipatch or Climara Pro could heighten risks associated with them.
Prolonged use of either medication without proper monitoring by your doctor can lead to serious health complications such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke and endometrial cancer among others. Regular check-ups with your physician are key when on this treatment regimen.
How much do Combipatch and Climara Pro cost?
For the brand name versions of these drugs:
- The price of 8 patches (0.05 mg/14 mcg) of Combipatch averages around $140, which works out to approximately $17.50 per patch or about $5.83/day if used as directed (every third day).
- The price for 4 patches of Climara Pro (0.045 mg/15 mcg) averages is about $130, working out to approximately $32.50 per patch and roughly the same daily cost ($10.83/day if changed weekly).
Thus, while individual patches are pricier with Climara Pro than Combipatch, they also last longer making their daily costs comparable.
Please note that cost should not be a primary consideration in determining which of these drugs is right for you.
As far as generic equivalents go:
- Currently there is no direct generic equivalent available for either Combipatch or Climara Pro.
It's important to remember that your healthcare provider will consider several factors such as your overall health condition, any other medications you may be taking and your personal response to medication when suggesting suitable options for you.
Popularity of Combipatch and Climara Pro
Combipatch, a hormone replacement therapy containing both estradiol and norethindrone to treat symptoms of menopause, was estimated to have been prescribed to about 1.2 million people in the US in 2020. Combipatch accounted for just over 10% of transdermal patch prescriptions in the US for menopausal symptom relief.
On the other hand, Climara Pro (estradiol/levonorgestrel), another form of hormone replacement therapy primarily used for postmenopausal osteoporosis prevention and symptomatic relief from hot flashes/vaginal atrophy associated with menopause, was prescribed to about 900 thousand people in the USA during the same period. In terms of overall HRT patch prescriptions within America, Climara Pro holds approximately an 8% share. Over the past decade, usage trends between these two options have remained fairly consistent - with Combipatch slightly leading due its dual action against both vasomotor symptoms as well as urogenital atrophy linked with declining estrogen levels during menopause.
Conclusion
Both Combipatch and Climara Pro are hormone replacement therapies used in the management of menopausal symptoms, particularly hot flashes and night sweats. They contain estrogen, which is supplemented with a progestin to protect the uterus from cancer risks associated with unopposed estrogen therapy.
Combipatch delivers both estradiol (a form of estrogen) and norethindrone acetate (a type of progestogen), whereas Climara Pro uses estradiol combined with levonorgestrel. The choice between these two may depend on individual patient factors such as tolerance or pre-existing medical conditions.
Both treatments come in patch form, offering convenience for those who prefer not to take oral medication. These patches are usually applied once or twice weekly depending upon the drug regimen prescribed by your physician.
Side effects can include breast tenderness, headaches, weight changes, and gastrointestinal issues among others for both medications. It's important that patients closely monitor their physical health while using hormone replacement therapy due to potential serious side effects like an increased risk of certain types of cancers or cardiovascular events.
Both drugs have generic versions available providing cost savings especially for those paying out-of-pocket.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Adler, G., Young, D., Galant, R., Quinn, L., Witchger, M. S., & Maki, K. C. (2005). A Multicenter, Open-Label Study to Evaluate Satisfaction and Menopausal Quality of Life in Women Using Transdermal Estradiol/Norethindrone Acetate Therapy for the Management of Menopausal Signs and Symptoms. Gynecologic and Obstetric Investigation. S. Karger AG.http://doi.org/10.1159/000084346
- Hickey, M. (2008, March). Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Clinical Interventions in Aging. Informa UK Limited.http://doi.org/10.2147/cia.s1043
- Dando, T. M., & Perry, C. M. (2004). 17??-Estradiol/Levonorgestrel Transdermal System. Treatments in Endocrinology. Springer Science and Business Media LLC.http://doi.org/10.2165/00024677-200403050-00005
- Notelovitz, M., Casselb, D., Hilleb, D., Furstb, K. W., Dain, M.-P., VandePol, C., & Skarinskyb, D. (2000, January). Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause. American Journal of Obstetrics and Gynecology. Elsevier BV.http://doi.org/10.1016/s0002-9378(00)70483-2
- Shulman, L. P. (2004, December). 17β-Estradiol/levonorgestrel transdermal system for the management of the symptomatic menopausal woman. Expert Opinion on Pharmacotherapy. Informa Healthcare.http://doi.org/10.1517/14656566.5.12.2559